{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:36:16Z","timestamp":1782891376254,"version":"3.54.5"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Gastric neuroendocrine neoplasms (g-NENs) represent a distinctive group of gastric tumors, stratified into different prognostic categories according to different histological characteristics, put forth in the 2018 World Health Organization classification system. The clinical presentations, as well as pathological features, represent important data in establishing the type of the tumor, in estimating the tumor behavior, and in selecting the best therapeutic strategy. In our case series we presented different clinical scenarios that may be encountered in practice regarding gastric NENs. We performed a literature review and discussed diagnostic strategy, current classification system, precursor lesions, and therapeutic options in g-NENs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>The first patient was a 41-year-old female with weight loss, persistent dyspeptic complaints and a history of pernicious anemia. In the second clinical case a 61-year-old man was admitted with heartburn, abdominal pain, diarrhea and mild iron deficiency anemia. The third patient was a 56-year-old male with a history of neoplasia, admitted for weight loss, dyspeptic complaints, and liver metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>All the 3 patients underwent upper endoscopy with targeted biopsies. Histopathological and laboratory evaluation, together with imagistic evaluation (abdominal ultrasound, endoscopic ultrasound, and magnetic resonance imaging) allowed the distinction between 3 different types of gastric tumors: type 1 enterochromaffin-like-cell G1 NET, type 2 enterochromaffin-like-cell G2 NET, and type 3 G2 NET with liver metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Endoscopic polypectomy of the largest lesion was performed in patient with type 1 g-NET and autoimmune chronic atrophic gastritis, followed by regular endoscopic surveillance with biopsies. In type 2 g-NET associated with pancreatic gastrinoma, pancreaticoduodenectomy with total gastrectomy were performed. In type 3 g-NET, detected in metastatic stage, oncologic therapy was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patients follow-up was selected according to tumor behavior, from regular endoscopic surveillance to oncology follow-up. The prognosis was good in case 1, whilst poorer outcomes were associated with more aggressive tumors in case 2 and case 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>g-NENs are rare tumors with distinct clinical and histological features. Our case series emphasized the role of close collaboration between clinician and pathologist, as well as the importance of a detailed pathology report.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028550","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T13:09:21Z","timestamp":1642165761000},"page":"e28550","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Gastric neuroendocrine neoplasms and precursor lesions"],"prefix":"10.1097","volume":"101","author":[{"given":"Alina","family":"Boeriu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dobru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crina","family":"Fofiu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Brusnic","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danusia","family":"Oni\u015for","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mocan","sequence":"additional","affiliation":[{"name":"Pathology Department, University of Medicine, Pharmacy, Science, and Technology of Targu Mures, Romania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/ajg.2010.341","article-title":"Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971","volume":"105","author":"Ellis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12253-011-9382-y","article-title":"Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry","volume":"17","author":"Caldarella","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1677\/ERC-10-0152","article-title":"Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters","volume":"17","author":"Niederle","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and out-comes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"e62487","DOI":"10.1371\/journal.pone.0062487","article-title":"The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1055\/s-0030-1255564","article-title":"Neuroendocrine tumors of the stomach (gastric carcinoids) are on rise, small tumors, small problems?","volume":"42","author":"Scherulb","year":"2010","journal-title":"Endoscopy"},{"key":"R10-20250504","first-page":"13","article-title":"Nomenclature and classification of neuroendocrine neoplasms of the digestive system","author":"Rindi","year":"2010","journal-title":"WHO Classification of Tumours of the Digestive System"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"R12-20250504","first-page":"104","article-title":"Gastric neuroendocrine neoplasms","author":"La Rosa","year":"2019","journal-title":"WHO Classification of Tumours of the Digestive System. Vol. 1"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2559.2006.02570.x","article-title":"Endocrine tumours of the gastrointestinal tract-selected topics","volume":"50","author":"Williams","year":"2007","journal-title":"Histopathology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4253\/wjge.v7.i4.346","article-title":"Endoscopic diagnosis and management of type I neuroendocrine tumors","volume":"7","author":"Sato","year":"2015","journal-title":"World J Gastrointest Endosc"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/jclinpath-2014-202515","article-title":"Gastric neuroendocrine neoplasms and related precursor lesions","volume":"67","author":"La Rosa","year":"2014","journal-title":"J Clin Pathol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.humpath.2013.02.005","article-title":"Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions","volume":"44","author":"Vanoli","year":"2013","journal-title":"Hum Pathol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/00042737-200112000-00008","article-title":"Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid","volume":"13","author":"Annibale","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger\u2013Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00199342","article-title":"Revised classification of neuroendocrine tumors of the lung, pancreas and gut","volume":"425","author":"Capella","year":"1995","journal-title":"Virchows Arch"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1369\/jhc.5A6770.2006","article-title":"Histidine decarboxylase, DOPA decarboxylase and vesicular monoamine transporter 2 expression in neuroendocrine tumors: immunohistochemical study and gene expression analysis","volume":"54","author":"Ucella","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bpg.2013.01.002","article-title":"Gastric and duodenal neuroendocrine tumours","volume":"26","author":"O\u2019Toole","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"791","DOI":"10.4251\/wjgo.v12.i8.791","article-title":"Gastrointestinal neuroendocrine tumors in","volume":"12","author":"Ahmed","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.humpath.2011.01.018","article-title":"Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms","volume":"42","author":"La Rosa","year":"2011","journal-title":"Hum Pathol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0960-7404(03)00034-3","article-title":"Carcinoid tumors of the stomach","volume":"12","author":"Modlin","year":"2003","journal-title":"Surg Oncol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004280050033","article-title":"Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors","volume":"436","author":"Rindi","year":"2000","journal-title":"Virchows Arch"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF02934114","article-title":"Gastric neuroendocrine carcinoma associated with chronic atrophic gastritis type A","volume":"32","author":"Kaizaki","year":"1997","journal-title":"J Gastroenterol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MEG.0b013e328350fae8","article-title":"Unusually aggressive type 1 gastric carcinoid: a case report with a review of the literature","volume":"24","author":"Spampatti","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12022-021-09681-2","article-title":"Pathogenic ATM variant-harbouring well-differentiated aggressive type 1 gastric neuroendocrine tumour with high-grade features (G3 NET): a new addition to the clinical and pathological spectrum of gastric neuroendocrine neoplasms","volume":"32","author":"Nassereddine","year":"2021","journal-title":"Endocr Pathol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00508-007-0879-z","article-title":"Diagnosis and treatment of gastric neuroendocrine tumours","volume":"119","author":"Pl\u00f6ckinger","year":"2007","journal-title":"Wien Klin Wochenschr"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2003-37256","article-title":"Endoscopic mucosal resection in the management of gastric carcinoid tumors","volume":"35","author":"Ichikawa","year":"2003","journal-title":"Endoscopy"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.suc.2016.11.008","article-title":"Neuroendocrine tumors of the stomach","volume":"97","author":"Corey","year":"2017","journal-title":"Surg Clin N Am"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hoc.2015.08.006","article-title":"Clinical presentation and diagnosis of neuroendocrine tumors","volume":"30","author":"Vinik","year":"2016","journal-title":"Hematol Oncol Clin N Am"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3748\/wjg.v20.i1.118","article-title":"Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors","volume":"20","author":"Li","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s101200300007","article-title":"A case of aggressive neuroendocrine carcinoma of the stomac","volume":"6","author":"Hosoya","year":"2003","journal-title":"Gastric Cancer"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.12998\/wjcc.v9.i27.7973","article-title":"Gastric neuroendocrine neoplasms: a review","volume":"9","author":"K\u00f6seo\u011flu","year":"2021","journal-title":"World J Clin Cases"},{"issue":"(Suppl 1)","key":"R39-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000080733","article-title":"Endocrine tumors of the gut and pancreas tumor biology and classification","volume":"80","author":"Rindi","year":"2004","journal-title":"Neuroendocrinology"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4251\/wjgo.v12.i8.850","article-title":"Gastric neuroendocrine tumor: a practical literature review","volume":"12","author":"Roberto","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"R41-20250504","first-page":"379","article-title":"Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia","volume":"57","author":"Hoshino","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jss.2010.01.005","article-title":"Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors","volume":"162","author":"Ozao","year":"2010","journal-title":"J Surg Res"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"287825","DOI":"10.1155\/2012\/287825","article-title":"Current concepts on gastric carcinoid tumors","volume":"2012","author":"Nikou","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"(Suppl 1)","key":"R44-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000080734","article-title":"Gastric neuroendocrine tumors","volume":"80","author":"Delle Fave","year":"2004","journal-title":"Neuroendocrinology"},{"key":"R45-20250504","first-page":"1524","article-title":"Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection","volume":"60","author":"Sato","year":"2013","journal-title":"Hepatogastroenterology"},{"key":"R46-20250504","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/253860","article-title":"The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection","volume":"2014","author":"Kim","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/2050640619890465","article-title":"Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: a systematic review and meta-analysis","volume":"8","author":"Rossi","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bcp.13146","article-title":"Netazepide, a gastrin\/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis","volume":"83","author":"Boyce","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bpg.2012.12.005","article-title":"Surgery for GEP-NETs","volume":"26","author":"Knigge","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ags3.12396","article-title":"Surgical treatment for gastrointestinal neuroendocrine tumors","volume":"4","author":"Eto","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM200008243430805","article-title":"Treatment of type II gastric carcinoid tumors with somatostatin analogues","volume":"343","author":"Tomassetti","year":"2000","journal-title":"N Engl J Med"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/apt.15765","article-title":"Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours","volume":"51","author":"Exarchou","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1464-410X.2006.06663.x","article-title":"Liver metastases in prostate carcinoma: clinical characteristics and outcome","volume":"99","author":"Pouessel","year":"2007","journal-title":"BJU Int"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13277-013-1083-6","article-title":"Clinical characteristics and prognosis factors of prostate cancer with liver metastases","volume":"35","author":"Wang","year":"2014","journal-title":"Tumor Biol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3121\/cmr.2010.855","article-title":"Prostate carcinoma metastatic to the stomach: report of two cases and review of the literature","volume":"8","author":"Onitilo","year":"2010","journal-title":"Clin Med Res"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.urology.2003.12.009","article-title":"Prostate cancer metastatic to the stomach","volume":"63","author":"Christoph","year":"2004","journal-title":"Urology"},{"key":"R57-20250504","article-title":"Gastric neuroendocrine neoplasm with late liver metastasis","volume":"2018","author":"Marques","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000445940","article-title":"Well-differentiated grade 2, type 3 gastrointestinal neuroendocrine tumour with bilateral metastatic ovarian involvement: report of an unusual case","volume":"9","author":"Manneh","year":"2016","journal-title":"Case Rep Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:24:50Z","timestamp":1746332690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028550"}},"subtitle":["Case reports and literature review"],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028550","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"2021-12-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}